Đang chuẩn bị liên kết để tải về tài liệu:
Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer

In the recent phase III trial MPACT the combination of gemcitabine and nab-paclitaxel (Gem/NabP) showed increased overall survival compared to gemcitabine alone in the treatment of advanced pancreatic ductal adenocarcinoma (aPDA). | Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer